[{"address1": "Dr. Neergaards Vej", "address2": "5th Floor", "city": "Horsholm", "zip": "2970", "country": "Denmark", "phone": "45 53 53 18 50", "website": "https://www.evaxion-biotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.", "fullTimeEmployees": 63, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christian  Kanstrup M.Sc.", "age": 51, "title": "Chief Executive Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 454000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andreas Holm Mattsson", "age": 47, "title": "Co-Founder and Chief AI & Culture Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 247000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Niels Iversen Moller M.D.", "age": 44, "title": "Co-Founder, VP of Business & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 120000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jesper Nyegaard Nissen M.Sc.", "age": 52, "title": "CFO & COO", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 346967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Birgitte  Rono Ph.D.", "age": 46, "title": "Chief Scientific Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 336000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J\u00fcrgen  Langh\u00e4rig EMBA, Ph.D.", "title": "Head of Business Development & Member of Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.95, "open": 2.95, "dayLow": 2.94, "dayHigh": 3.0692, "regularMarketPreviousClose": 2.95, "regularMarketOpen": 2.95, "regularMarketDayLow": 2.94, "regularMarketDayHigh": 3.0692, "beta": -0.003, "forwardPE": -0.79733336, "volume": 8221, "regularMarketVolume": 8221, "averageVolume": 686889, "averageVolume10days": 44620, "averageDailyVolume10Day": 44620, "bid": 3.03, "ask": 3.29, "bidSize": 4000, "askSize": 3100, "marketCap": 14386564, "fiftyTwoWeekLow": 2.824, "fiftyTwoWeekHigh": 18.5, "fiftyDayAverage": 4.99762, "twoHundredDayAverage": 8.493555, "currency": "USD", "enterpriseValue": 128917248, "floatShares": 34541359, "sharesOutstanding": 4811560, "sharesShort": 19395, "sharesShortPriorMonth": 49810, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0057, "heldPercentInsiders": 0.17992, "heldPercentInstitutions": 0.01012, "shortRatio": 0.15, "impliedSharesOutstanding": 37907000, "bookValue": -0.983, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -24474000, "trailingEps": -9.5, "forwardEps": -3.75, "lastSplitFactor": "1:10", "lastSplitDate": 1705881600, "enterpriseToEbitda": -5.457, "52WeekChange": -0.70970875, "SandP52WeekChange": 0.29495108, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "EVAX", "underlyingSymbol": "EVAX", "shortName": "Evaxion Biotech A/S", "longName": "Evaxion Biotech A/S", "firstTradeDateEpochUtc": 1612535400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "10e58503-7bd5-32f9-974e-d651a4f9f505", "messageBoardId": "finmb_319014926", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.99, "targetHighPrice": 20.0, "targetLowPrice": 14.0, "targetMeanPrice": 18.0, "targetMedianPrice": 20.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 2605000, "totalCashPerShare": 0.064, "ebitda": -23624750, "totalDebt": 10306000, "quickRatio": 0.722, "currentRatio": 1.462, "operatingCashflow": -21515000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-17"}]